Psychiatrist Robert Custer spent his life convincing doctors that compulsive gambling was not an impulse control problem.

BioLizard has supported the development of novel biomarker programs, contributed to AI-driven drug discovery efforts, and ...

Discusses Oncology Pipeline Advances and Phase III Clinical Updates at Science and Technology Day December 15, ...

The family’s pillar needs someone to lean on, too, so the government is moving to follow up on a study pitching a strong telepsychiatry program for OFWs to support their mental health abroad.

In August 2021, University of Chicago Prof. Oeindrila Dube began reviewing data on a first-of-its-kind police training ...

My name is Todd Tushla, I'm the Vice President of Investor Relations at Neurocrine Biosciences. And on behalf of our entire company, welcome to our 2025 R&D Day, whether you're here in person, on the ...

The annual report details many accomplishments that are illustrative of the momentum we have been building for decades.

Reclassification to a Schedule III drug and possible Medicare coverage for pot could unlock new investment from ...

A new program at the Department of Energy is pushing the development of nearly a dozen new reactor designs at breakneck speed.

Rhipicephalus microplus, known as the Southern cattle fever tick, are vectors of bovine babesiosis, a deadly disease for ...

How BioRender and CEO Shiz Aoki are turning a standard visual language for biology into must-have AI infrastructure, from ...

Experts are increasingly turning to machine learning to predict antibiotic resistance in pathogens. With its help, resistance ...